175 related articles for article (PubMed ID: 29735450)
1. [Expression of phosphoglycerate kinase 1 in endometrial carcinoma and its association with patients' outcome].
Lin L; Jiang QP; Lin D; Chen W; Jiang HP; Liu CH; Xiao YY; Zhu LT; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):471-476. PubMed ID: 29735450
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of DAPK3 and c-Myc in endometrial cancer and their relationship with the patients' prognosis].
Chen C; Guo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):863-9. PubMed ID: 27320893
[TBL] [Abstract][Full Text] [Related]
3. [Influence of phosphoglycerate kinase 1 on metastasis and invasion of hepatoma cells and prognosis of liver cancer].
Zhang L; Wang YC; Xie XY; Chen J; Gao DM; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):446-451. PubMed ID: 28763863
[No Abstract] [Full Text] [Related]
4. PGK1 and GRP78 overexpression correlates with clinical significance and poor prognosis in Chinese endometrial cancer patients.
Guo S; Xiao Y; Li D; Jiang Q; Zhu L; Lin D; Jiang H; Chen W; Wang L; Liu C; Fang W; Lin L
Oncotarget; 2018 Jan; 9(1):680-690. PubMed ID: 29416645
[TBL] [Abstract][Full Text] [Related]
5. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
Zhou JW; Tang JJ; Sun W; Wang H
Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
Sun S; Liang X; Zhang X; Liu T; Shi Q; Song Y; Jiang Y; Wu H; Jiang Y; Lu X; Pang D
Br J Cancer; 2015 Apr; 112(8):1332-9. PubMed ID: 25867275
[TBL] [Abstract][Full Text] [Related]
7. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
[TBL] [Abstract][Full Text] [Related]
8. Expression of ER, PR, C-erbB-2 and Ki-67 in Endometrial Carcinoma and their Relationships with the Clinicopathological Features.
Yu CG; Jiang XY; Li B; Gan L; Huang JF
Asian Pac J Cancer Prev; 2015; 16(15):6789-94. PubMed ID: 26434913
[TBL] [Abstract][Full Text] [Related]
9. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
10. Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its clinical significance.
Hu Y; Yu L; Xia F; Liang F; Cheng C; Huang Y; Xiao L
Clin Transl Oncol; 2021 Aug; 23(8):1711-1716. PubMed ID: 33635467
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
12. Overexpression of HPIP as a biomarker for metastasis and prognosis prediction in endometrial cancer patients.
Cheng L; Zhao T; Li S; Wang Y; Fei H; Meng F
J Clin Lab Anal; 2019 Oct; 33(8):e22959. PubMed ID: 31241209
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of MMSET in endometrial cancer: a clinicopathologic study.
Xiao M; Yang S; Chen J; Ning X; Guo L; Huang K; Sui L
J Surg Oncol; 2013 Mar; 107(4):428-32. PubMed ID: 22886632
[TBL] [Abstract][Full Text] [Related]
14. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
Li P; Yin H; Meng F; Liu S; Liu H; Ma R
Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
[TBL] [Abstract][Full Text] [Related]
15. Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging.
Zieker D; Königsrainer I; Weinreich J; Beckert S; Glatzle J; Nieselt K; Bühler S; Löffler M; Gaedcke J; Northoff H; Mannheim JG; Wiehr S; Pichler BJ; von Weyhern C; Brücher BL; Königsrainer A
Cell Physiol Biochem; 2010; 26(2):147-54. PubMed ID: 20798498
[TBL] [Abstract][Full Text] [Related]
16. Phosphoglycerate-kinase-1 Is a Potential Prognostic Biomarker in HNSCC and Correlates With Immune Cell Infiltration.
Wang P; Wang YY; Xu YL; Zhang CY; Wang K; Wang Q
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):723-734. PubMed ID: 38035710
[TBL] [Abstract][Full Text] [Related]
17. Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Cancer.
Lu W; Gao J; Yang J; Cao Y; Jiang L; Li M; Zhang Y; Zhou J; Liu Y
Medicine (Baltimore); 2015 Dec; 94(49):e2244. PubMed ID: 26656369
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome.
Kong Y; Ren Z
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8113-8118. PubMed ID: 30556848
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
20. Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy.
Fu Q; Yu Z
Life Sci; 2020 Sep; 256():117863. PubMed ID: 32479953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
